| [1] |
Weng G, Li F, Xu M. Pilomatrix carcinoma of the male breast: a case report[J]. Int J Clin Exp Pathol, 2020, 13(8): 2153-2157.
|
| [2] |
Lopansri S, Mihm MC Jr. Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: a case report and review of literature[J]. Cancer, 1980, 45(9): 2368-2373. DOI: 10.1002/1097-0142.
doi: 10.1002/1097-0142
pmid: 7379033
|
| [3] |
White C, Farsi M, Esguerra D, et al. Not your average skin cancer: a rare case of pilomatrix carcinoma[J]. J Clin Aesthet Dermatol, 2020, 13(6): 40-42.
|
| [4] |
Melancon JM, Tom WL, Lee RA, et al. Management of pilomatrix carcinoma: a case report of successful treatment with Mohs micrographic surgery and review of the literature[J]. Dermatol Surg, 2011, 37(12): 1798-1805. DOI: 10.1111/j.1524-4725.2011.02170.x.
doi: 10.1111/j.1524-4725.2011.02170.x
pmid: 22093235
|
| [5] |
Alcántara-González J, Sánchez-Largo ME, Caminoa A, et al. Pilomatrix carcinoma: a rare cause of facial tumor[J]. Dermatol Online J, 2014, 20(7): 13030/qt5ct4m4w1. DOI: 10.5070/D3207023135.
doi: 10.5070/D3207023135
|
| [6] |
Lazar AJ, Calonje E, Grayson W, et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin[J]. J Cutan Pathol, 2005, 32(2): 148-157. DOI: 10.1111/j.0303-6987.2005.00267.x.
doi: 10.1111/j.0303-6987.2005.00267.x
pmid: 15606674
|
| [7] |
Aherne NJ, Fitzpatrick DA, Gibbons D, et al. Recurrent malignant pilomatrixoma invading the cranial cavity: improved local control with adjuvant radiation[J]. J Med Imaging Radiat Oncol, 2009, 53(1): 139-141. DOI: 10.1111/j.1754-9485.2009.02049.x.
doi: 10.1111/j.1754-9485.2009.02049.x
|
| [8] |
Papadakis M, de Bree E, Floros N, et al. Pilomatrix carcinoma: more malignant biological behavior than was considered in the past[J]. Mol Clin Oncol, 2017, 6(3): 415-418. DOI: 10.3892/mco.2017.1148.
doi: 10.3892/mco.2017.1148
pmid: 28451423
|
| [9] |
Ng WT, Lee MC, Chang AT, et al. The impact of dosimetric in-adequacy on treatment outcome of nasopharyngeal carcinoma with IMRT[J]. Oral Oncol, 2014, 50(5): 506-512. DOI: 10.1016/j.oraloncology.2014.01.017.
doi: 10.1016/j.oraloncology.2014.01.017
|
| [10] |
Thamlikitkul L, Petsuksiri J, Ithimakin S. Post-operative concurrent chemoradiation for patients with non-squamous cell carcinoma of head and neck: a retrospective cohort of the uncommon cancers[J]. Asian Pac J Cancer Prev, 2019, 20(6): 1727-1734. DOI: 10.31557/APJCP.2019.20.6.1727.
doi: 10.31557/APJCP.2019.20.6.1727
|
| [11] |
Onderdonk BE, Vokes EE, Gwede M, et al. Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience[J]. Health Sci Rep, 2020, 3(4): e195. DOI: 10.1002/hsr2.195.
doi: 10.1002/hsr2.195
pmid: 33043152
|
